MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study

MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study

Aims: Non-invasive measures of brain iron content would be of great benefit in neurodegeneration with brain iron accumulation (NBIA) to serve as a biomarker for disease progression and evaluation of iron chelation therapy. Although magnetic resonance imaging (MRI) provides several quantitative measu...

Full description

Bibliographic Details
Main Authors:	Lena H.P. Vroegindeweij, Piotr A. Wielopolski, Agnita J.W. Boon, J.H. Paul Wilson, Rob M. Verdijk, Sipeng Zheng, Sylvestre Bonnet, Lucia Bossoni, Louise van der Weerd, Juan A. Hernandez-Tamames, Janneke G. Langendonk
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	NeuroImage
Subjects:	Aceruloplasminemia Neurodegeneration with brain iron accumulation (NBIA) Postmortem MRI Iron Transverse relaxation rate (R2*) Susceptibility
Online Access:	http://www.sciencedirect.com/science/article/pii/S1053811921010247

Similar Items

Quantification of different iron forms in the aceruloplasminemia brain to explore iron-related neurodegeneration
by: Lena H.P. Vroegindeweij, et al.
Published: (2021-01-01)

Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports
by: Lena H. P. Vroegindeweij, et al.
Published: (2020-04-01)

BRAIN IRON ACCUMULATION: DON’T FORGET ACERULOPLASMINEMIA
by: Paola Feraco
Published: (2020-07-01)

Aceruloplasminemia Presenting with Cognitive Impairment
by: Yıldız Arslan, et al.
Published: (2017-09-01)

Dementia as a core clinical feature of a patient with aceruloplasminemia
by: Farzad Ashrafi, et al.
Published: (2022-03-01)

Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis
by: Giacomo Marchi, et al.
Published: (2019-04-01)

Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis
by: Marc Vila Cuenca, et al.
Published: (2020-03-01)

Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
by: Alan Zanardi, et al.
Published: (2018-01-01)

A New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report
by: Hervé Lobbes, et al.
Published: (2022-05-01)

Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition
by: Sonia Levi, et al.
Published: (2019-02-01)

Aceruloplasminemia with novel mutation, with IgG4 related pachymeningitis – occam's razor or hickam's dictum?
by: Sai D Yaranagula, et al.
Published: (2023-01-01)

Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy
by: Nicola Romano, et al.
Published: (2022-08-01)

Cerebral Iron Deposition in Neurodegeneration
by: Petr Dusek, et al.
Published: (2022-05-01)

Brain MRI Pattern Recognition in Neurodegeneration With Brain Iron Accumulation
by: Jae-Hyeok Lee, et al.
Published: (2020-09-01)

Molecular and pathological basis of aceruloplasminemia
by: SATOSHI KONO, et al.
Published: (2006-01-01)

An international registry for neurodegeneration with brain iron accumulation
by: Kalman Bernadette, et al.
Published: (2012-09-01)

Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.
by: Sonia eLevi, et al.
Published: (2014-05-01)

Gene co-expression networks shed light into diseases of brain iron accumulation
by: Conceição Bettencourt, et al.
Published: (2016-03-01)

Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy
by: Mattia Fonderico, et al.
Published: (2017-08-01)

An overview of Neurodegeneration with brain iron accumulation (NBIA) syndromes and the disease status in Iranian population: review article
by: Reza Hajati, et al.
Published: (2020-04-01)

Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
by: Thomas Klopstock, et al.
Published: (2023-08-01)

Botulinum Toxin-A Injection in the Treatment of Spasticity in a Infantile-Onset Neurodegeneration With Brain Iron Accumulation: A Case Report
by: Hwan Kwon Do, et al.
Published: (2018-04-01)

Estimation of postmortem interval by postmortem myocardial computed tomography value
by: Zhiyuan An, et al.
Published: (2021-01-01)

Cortical pencil lining on SWI MRI in NBIA and healthy aging
by: Marlous C. M. van der Weijden, et al.
Published: (2019-10-01)

Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients
by: Paolo Santambrogio, et al.
Published: (2015-09-01)

Neuronal Ablation of CoA Synthase Causes Motor Deficits, Iron Dyshomeostasis, and Mitochondrial Dysfunctions in a CoPAN Mouse Model
by: Ivano Di Meo, et al.
Published: (2020-12-01)

A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN)
by: Nabil Al Macki, et al.
Published: (2017-01-01)

Inherited Disorders of Iron Overload
by: Kostas Pantopoulos, et al.
Published: (2018-10-01)

Multidisciplinary approach to postmortem diagnostics
by: Milena V. Lozina, et al.
Published: (2023-06-01)

Postmortem tissue changes and dynamics of their impedance parameters: a preclinical experimental study
by: O. S. Lavrukova, et al.
Published: (2023-10-01)

Postmortem Alteration of Purine Metabolism in Coronary Artery Disease
by: Phakchira Somtua, et al.
Published: (2023-11-01)

Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism
by: Camilla Ceccatelli Berti, et al.
Published: (2015-04-01)

Neurodegeneration with brain iron accumulation: A case report
by: Daniel Nassif, et al.

Postmortem Metabolomics: Strategies to Assess Time-Dependent Postmortem Changes of Diazepam, Nordiazepam, Morphine, Codeine, Mirtazapine and Citalopram
by: Lana Brockbals, et al.
Published: (2021-09-01)

Akut Endosülfan Zehirlenmesinde Postmortem Organ Dağılımı : Olgu Sunumu
by: Nebile DAĞLIOĞLU, et al.
Published: (2013-09-01)

In vitro fertilization postmortem
by: Patricia Sánchez Ruiz, et al.
Published: (2018-05-01)

Application and Prospect of Postmortem Imaging Technology in Forensic Cardiac Pathology: A Systemic Review
by: Ningguo Liu, et al.
Published: (2022-01-01)

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
by: Paolo Santambrogio, et al.
Published: (2020-05-01)

Editorial: Movement disorders in neurometabolic conditions
by: Divyani Garg, et al.
Published: (2024-03-01)

Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias
by: Dolores Martínez-Rubio, et al.
Published: (2022-10-01)